Correlation Between Catalyst Pharmaceuticals and GOLDMAN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and GOLDMAN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and GOLDMAN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and GOLDMAN SACHS GROUP, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and GOLDMAN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of GOLDMAN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and GOLDMAN.

Diversification Opportunities for Catalyst Pharmaceuticals and GOLDMAN

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Catalyst and GOLDMAN is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and GOLDMAN SACHS GROUP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GOLDMAN SACHS GROUP and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with GOLDMAN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GOLDMAN SACHS GROUP has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and GOLDMAN go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and GOLDMAN

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 4.89 times more return on investment than GOLDMAN. However, Catalyst Pharmaceuticals is 4.89 times more volatile than GOLDMAN SACHS GROUP. It trades about 0.08 of its potential returns per unit of risk. GOLDMAN SACHS GROUP is currently generating about 0.01 per unit of risk. If you would invest  1,162  in Catalyst Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  1,045  from holding Catalyst Pharmaceuticals or generate 89.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.73%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  GOLDMAN SACHS GROUP

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
GOLDMAN SACHS GROUP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GOLDMAN SACHS GROUP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, GOLDMAN is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Catalyst Pharmaceuticals and GOLDMAN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and GOLDMAN

The main advantage of trading using opposite Catalyst Pharmaceuticals and GOLDMAN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, GOLDMAN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GOLDMAN will offset losses from the drop in GOLDMAN's long position.
The idea behind Catalyst Pharmaceuticals and GOLDMAN SACHS GROUP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital